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Background: Up to 80% of patients with rectal cancer undergo sphincter-saving surgery, and almost 90% of them
experience subsequent physical changes. The number of studies on gender differences in response to this surgery
has increased, and the connection between gender and symptoms and patient outcomes has generated increasing
interest. Nevertheless, little is known about the gender differences in quality of life and cancer-related symptoms.
We examined gender differences and quality of life changes over a 1-year period among patients with lower rectal
cancer who were treated with sphincter-saving surgery.
Methods: Patients (men = 42; women = 33) completed a self-administered questionnaire on their quality of life and
related factors before surgery and 1, 6, and 12 months afterwards. The questionnaire was developed by the European
Organization for Research and Treatment of Cancer (EORTC QLQ-C30/CR-38).
Results: Scores on physical, role, and social functioning and global health status/quality of life decreased 1 month after
surgery, improved after 6 months, and returned to baseline within 12 months, with the exception of social functioning
in men. Factors related to quality of life changed after surgery and differed between men and women. Women’s global
health status/quality of life was affected by fatigue, weight loss, defecation problems, and future perspective, while that
of men was affected by fatigue, weight loss, future perspective, and role functioning, which was affected by pain,
defecation problems, and financial difficulties.
Conclusions: Gender differences should be considered when predicting the quality of life of cancer patients
undergoing surgery. Identifying gender differences will help health care providers anticipate the unique needs of
patients undergoing surgery for rectal cancer.
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Rectal cancer is one of the most common malignant
tumors, and sphincter-saving surgery (SSS) and abdomi-
noperineal resection (APR) have been widely used to
treat rectal cancer. The psychological needs of patients
undergoing APR are of greater concern than those
undergoing SSS because people can imagine the handicap
caused by this major change, including the care of per-
manent stoma after APR. Due to the decreased quality of
life (QOL) that accompanies APR with a permanent
stoma, it tends to be avoided, and low anterior resection
(LAR) is chosen instead [1].
Disorders of sexual, urinary, and bowel function might
result from surgery for rectal cancer, and the dysfunction
may influence the patient’s QOL. Traa et al. reported
that treatment groups of 439 patients with rectal cancer
had lower QOL and sexual functioning compared to the
general population [2]. Chambers et al. identified a per-
manent stoma as a risk factor for a lower QOL [3].
That study reported that rectal cancer patients having
SSS might experience symptoms affecting their QOL
that are different from those of stoma patients. However,
the study’s conclusions did not appear in a meta-analysis
conducted by Cornish et al. or in a systematic review by
Pachler and Wille-Jørgensen published in the Cochrane
Database [4,5].
In recent years, the demand for SSS has increased in
patients with middle or low rectal cancer because of the
esthetic appeal of the lower-sited anastomosis due to the
development of surgical techniques. Although patients
undergoing SSS have defecation problems, they request
surgery to avoid having a permanent stoma. The tech-
niques of SSSs include LAR, ultra-low anterior resection
(ULAR), and intersphincteric resection (ISR). LAR is
commonly used when the cancer has affected the middle
rectum. The ULAR includes anastomoses at 2 cm from
the dentate line. The ISR is the ultimate SSS for very
low rectal cancer, which includes a partial resection of
the internal anal sphincter [6].
Bryant et al. reported that up to 80% of rectal cancer
patients undergo SSS [7]. Up to 90% of patients who
undergo SSS will experience changes in their bowel
habits, changes that range from heightened bowel fre-
quency to fecal incontinence or evacuatory dysfunction.
Moreover, sexual dysfunction and dysuria frequently
occur after surgery for lower rectal cancer.
Desnoo and Faithfull, Nikolette et al., and Landers et al.
described the experience and management of defecation
problems in patients after SSS in three qualitative studies
and argued for the need to strengthen support for them
[8-10]. A grasp of the problems associated with anorectal
symptoms and QOL after SSS is important for the care of
patients with lower rectal cancer. There are previous stud-
ies on APR (AR and LAR); however, estimates of QOLafter APR and SSS have been controversial [5]. Few studies
have focused on the QOL of patients undergoing SSS. An
analysis of data on SSS and QOL using the European
Organization for the Research and Treatment of Cancer
Core Quality of Life Questionnaire (EORTC QLQ-C30
and CR38) found a higher QOL in patients treated with
the high anterior resection than those treated with LAR
and APR [1]. Therefore, LAR patients require more atten-
tion because of their lower QOL scores compared with the
APR patients. Although patients with a low anastomosed
line 3 cm apart from the anal verge had incontinence of
gas and feces, no difference in QOL was found on the
EORTC QLQ-C30/CR38, compared with patients with
higher anastomosis [11].
Camilleri-Brennan and Steele observed that patients’
QOL after rectal cancer surgery deteriorated immedi-
ately and changed over time [12]. Schmidt et al. found
that the majority of QOL scores fell below baseline in
the early postoperative period [13]. In a prospective
study, Andersson et al. compared the QOL of a patient
subset from a randomized trial (N = 385) 12 months
after laparoscopic versus open surgery for rectal cancer
[14]. Changes in EORTC QLQ-C30 and CR38 were not
significantly different between the groups. Physical, role,
and social functioning and fatigue, as measured by the
EORTC QLQ-C30, revealed a substantial deterioration
1 month after surgery. All of the functional and symp-
tom scores improved after 6 months and returned to
baseline levels within 12 months. The early postopera-
tive period is important for patients to accept changes
caused by surgery, and thereafter, to accommodate to
postoperative life. However, gender differences were
not considered.
Little is known about the gender differences in QOL,
and studies on cancer-related symptoms have yielded
conflicting results [15]. In a study by Hjermstad et al.,
Norwegian women reported lower functional status and
global health status/QOL than did their male counter-
parts, and Schwarz and Hinz reported similar findings in
the general German population [16,17]. Fayers et al.
concluded that the effects of age and gender based on
reference data from the EORTC QLQ-C30 (+3) must be
considered when interpreting data on the QOL of cancer
patients [18]. Little is known about the association
between patients’ gender and their differing perceptions
of their QOL after surgery for rectal cancer. Schmidt
et al. reported that QOL scores often decreased signifi-
cantly during the period soon after surgery [19]. From
the third month after surgery, global health status/QOL,
emotional functioning, and physical functioning improved.
Women had significantly inferior scores on global health
status/QOL and physical functioning and higher scores on
treatment strain and fatigue. Men declared difficulties with
sexual enjoyment; gradually, sexual problems caused high
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levels in the period soon after surgery.
To our knowledge, there are no existing studies investi-
gating gender differences in the longitudinal QOL changes
among patients with lower rectal cancer after only SSS.
Therefore, the purpose of this study was to examine gender
differences in the changes in QOL before and after SSS in
patients with lower rectal cancer.
Methods
Study population and data collection
The inclusion criteria for participation in this study were
patients who (1) had the psychological capability of com-
pleting the QOL questionnaires, (2) were adults (over
20 years of age), (3) had clinical stage I to IIIb cancer but
not metastasis, and (4) had no postoperative complica-
tions. Patients with lower rectal cancer underwent primary
surgery at the study hospitals between November 2008
and March 2013.
A researcher explained the study protocol to the pa-
tients. The patients who agreed to participate in the
study completed the self-administered questionnaires.
The self-administered questionnaires were mailed or
hand delivered to the participants immediately before
the surgery in the hospital and at 1-, 6-, and 12-month
intervals following their operations. Clinical data were
gathered from each institutional database. All collected
questionnaires were coded and stored in a secure loca-
tion to protect the patients’ privacy. Eighty-eight patients
who had SSS provided a written consent; 85 agreed to
participate in the study. Postoperative complications
showed anastomotic leakage in two cases: men and
women with ISR and the ULAR group. Accordingly, we
excluded all participants in these cases, and 75 com-
pleted the entire set (four administrations) of question-
naires. Ethical approval was obtained from the review
boards of the university and hospital in which the study
was conducted.
Therapy
The operations were performed by laparoscopic surgery.
Intestinal continuity was restored by performing a
straight anastomosis. Diversion was accomplished with a
temporary loop ileostomy. The diversion was used se-
lectively in patients, based on whether the surgeon
thought they would be at high risk for an anastomotic
leak. Twenty-four (18 men) of 75 patients had temporary
loop ileostomies after ISR and ULAR. The median
length of time for the closure of the loop ileostomies,
from surgery to stoma reversal, was 167.5 days: range =
17 to 425 days (men: 176.0 days, range = 17 to 425 days;
women: 166.5 days, range = 108 to 292 days).
Neoadjuvant radio-chemotherapy is the standard ther-
apy for patients with locally advanced rectal cancer inWestern countries. However, in Japan, surgery without
neoadjuvant radiotherapy is the standard procedure for
patients with stage T3 to T4 lower rectal cancer because
lateral lymph node dissection is a standard procedure as
opposed to radiotherapy in Japan. Only seven (6 men)
patients from ISR and ULAR group received neoadjuvant
and adjuvant chemotherapy, with the strategy of neoadju-
vant chemotherapy being the facilitation of sphincter pres-
ervation by potential downstaging. Moreover, in general,
patients begin a 6-month course of adjuvant chemother-
apy within 2 months after surgery. Some patients might
refuse chemotherapy because of adverse events.
Questionnaires
The European Organization for Research and Treatment
of Cancer (EORTC) Quality of Life Questionnaire
(QLQ)-C30 version 3.0, also referred to as the EORTC
QLQ-C30, is a questionnaire measuring the QOL of pa-
tients who have cancer [18,20,21]. It includes a global
health status/QOL scale, five multi-item functional
scales, and nine multi-item symptom scales. The five
multi-item functional scales measured physical, role,
emotional, cognitive, and social functioning, and the
nine multi-item symptom scales measured fatigue, nausea
and vomiting, pain, dyspnea, insomnia, appetite loss, con-
stipation, diarrhea, and financial difficulties.
The Japanese version of the EORTC QLQ-CR38 as-
sesses QOL in colorectal cancer patients and includes four
functional scales (body image, sexual functioning, sexual
enjoyment, and future perspective) and eight symptom
scales/items (micturition problems, chemotherapy side
effects, gastrointestinal tract symptoms, male sexual prob-
lems, female sexual problems, defecation problems,
stoma-related problems, and weight loss) [18,20,22]. We
obtained permission for the use of this questionnaire from
EORTC Quality of Life Group (Brussel, Belgium). Scores
range from 0 to 100. Higher scores on global health sta-
tus/QOL and the five multi-item functional scales indicate
higher levels of functioning, and higher scores on the
symptoms scales represent higher levels of symptoms.
Osoba et al. suggested that a change of five to ten points
in a patient’s score indicates a minimal change, whereas a
change of more than 20 points indicates a substantial
change [23].
Cronbach’s α was calculated for the following mea-
sures: global health status/QOL (0.738 to 0.916), physical
functioning (0.849 to 0.881), role functioning (0.925 to
0.952), emotional functioning (0.738 to 0.916), cognitive
functioning (0.624 to 0.800), and social functioning
(0.802 to 0.850).
Statistical methods
Statistical analyses of the scores on the EORTC ques-
tionnaires were performed in accordance with the
Table 1 Demographic and rectal cancer-related






Mean age (SD) in years 60.6 (10.6) 57.5 (7.6) 0.160
Occupational status (%)
Employed full or part-time 14 33.3 15 45.5 0.285
Unemployed 28 66.7 18 54.5
Marital status
Married 41 97.6 32 97.0 1.000
Other 1 2.4 1 3.0
Living with others
No 1 2.4 4 12.1 0.093
Yes 41 97.6 29 87.9
Clinical stage (tumor node metastasis)
I 22 52.4 18 54.5 0.488
II 6 14.3 7 21.2
IIIa 9 21.4 3 9.1
IIIb 5 11.9 5 15.2
Surgery type
ISR (temporary ileostomies) 11 (11) 26.2 5 (4) 15.2 0.099
ULAR (temporary ileostomies) 16 (7) 38.1 8 (2) 24.2
LAR 15 35.7 20 60.6
Neoadjuvant chemotherapy
No 36 88.1 32 97.0 0.096
Yes 6 11.9 1 3.0
Adjuvant chemotherapy
No 24 57.1 21 63.6 0.371
Yes 18 42.9 12 36.4
Radiation
No 42 100.0 33 100.0 1.000
Yes 0 0.0 0 0.0
Surgery: ISR intersphincteric resection, ULAR ultra-low anterior resection,
LAR low anterior resection.
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scores to a linear scale ranging from 0 to 100. Mann-
Whitney U and chi-square tests were used to make com-
parisons between the groups [18]. Data from the follow-up
study were analyzed using a repeated-measure ANOVA
(gender × time factor) and the Bonferroni test. This study
aimed to include at least 46 participants/arm, which was
expected to yield power ≥0.80, based on α ≤ 0.05, and
assuming a medium effect size (i.e., f = 0.25; Cohen, 1977).
Spearman’s correlation coefficient was used to examine
the relationship between global health status/QOL and
the functional and symptom scales (EORTC QLQ-C30).
Spearman correlations were performed to analyze any
relationships between the predictors and QOL. Multiple
linear regression analysis (stepwise) was performed on
the independent predictors of EORTC QLQ-C30/CR38
scores. Variables correlated with global health status/
QOL (P < 0.1) were included in the Spearman correla-
tions as independent variables predictive of QOL magni-
tude in women and men separately. Separate multiple
linear regression analyses (stepwise) were conducted for
men and women to identify the independent variables
(EORTC QLQ-C30 and CR38) predictive of global
health status/QOL (dependent variable). The level of
statistical significance was set to 0.05. SPSS (Version
21.0 for Windows, Tokyo, Japan) and was used for all
statistical analyses.
Results
The mean ages of the final sample of 42 men and 33
women were 60.6 and 57.5 years, respectively (Table 1).
There was no significant difference in age according to
gender (P = 0.160), and no significant differences in clinical
information (clinical stage, surgery type, chemotherapy,
and radiation) or social information (occupational status,
marital status, and living with others) between the two
groups. However, temporary ileostomy rates was found to
be statistically significant across the gender (men: 42.9%
versus women: 18.2%, P = 0.023). Overall, treatment
duration was also statistically significant (men: 437.9 ±
126.5 days (range = 365 to 790 days) versus women
391.6 ± 65.8 days (range = 365 to 657 days), P = 0.037).
Changes in EORTC QLQ-C30 and CR38 scores
Changes in participants’ scores on the EORTC QLQ-
C30 and the EORTC QLQ-CR38 are presented in Tables 2
and 3, respectively. Before surgery, the patients’ scores on
global health status/QOL and social functioning were
more than ten points lower than the reference data (gen-
eral German population). We found a small decrease in
global health status/QOL 1 month after surgery and an
improvement after 6 months. Physical, role, and social
functioning deteriorated significantly 1 month after sur-
gery, improved after 6 months, and returned to baselinelevels by 12 months, with the exception of role and social
functioning in men. Role functioning showed the largest
decrease 1 month after surgery, and scores were more
than 20 points below baseline for both genders. However,
there were no significant changes in emotional or cognitive
functioning in either group during the 12 months following
surgery.
A significant gender difference was found in social
functioning 12 months after surgery, with men scoring
significantly lower (73.4) than women (85.9) (see Table 2).
Other QOL dimensions failed to differ significantly
between the genders. Micturition problems were signifi-
cantly worse for men after surgery. Measures of physical
symptoms, such as appetite loss, indicated significant
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(T0, T1, T2, T3)
Men Women
Mean Mean Mean Mean Mean Mean Mean Mean Mean Mean P values P values P values




72.7 61.5 53.8 64.5 64.7 69.2 57.8 56.1 68.2 70.7 <0.001 0.099 0.566 0.005 0.411 0.013
22.2 21.1 25.2 24.2 20.2 21.9 23.5 25.5 20.0 21.8 T1 < T2**
T1 < T3***
Functional scales
Physical functioning 92.0 92.2 82.9 90.6 90.3 88.7 87.9 81.6 89.1 90.5 <0.001 0.122 0.447 0.008 0.584 0.008





89.8 84.5 63.5 75.4 76.6 86.6 77.8 57.6 79.8 84.3 <0.001 0.209 0.997 0.000 0.060 0.036





81.8 78.3 74.8 79.9 80.5 76.3 76.5 79.6 85.4 80.3 0.170 0.024 0.559 0.005 0.456 0.011
18.8 20.6 25.3 19.9 18.8 22.2 18.3 24.6 14.1 23.7
Cognitive
functioning
92.7 83.7 78.0 79.4 78.2 90.1 81.3 83.8 82.8 85.4 0.845 0.003 0.339 0.013 0.130 0.026
15.0 17.8 23.0 18.3 20.3 18.4 19.9 18.4 18.8 17.1
Social
functioning
92.0 77.8 65.3 73.4 73.4 90.3 77.3 68.7 82.3 85.9 <0.001 0.094 0.187 0.024 0.141 0.025


















Table 2 EORTC QLQ-C30v3 scores by time and gender (N = 75) (Continued)
Symptom scales/
items (#)
Fatigue 14.0 23.3 35.6 22.8 23.8 19.5 28.3 35.7 29.0 25.9 <0.001 0.090 0.290 0.015 0.632 0.007





1.8 0.8 3.6 1.2 1.6 3.6 3.0 6.6 3.5 3.0 0.063 0.038 0.163 0.026 0.860 0.002
7.6 3.6 10.8 4.3 6.2 11.4 8.8 18.1 10.0 7.7
Pain 13.0 14.7 26.2 16.3 17.1 17.2 20.2 18.7 16.2 11.6 0.064 0.035 0.649 0.003 0.148 0.025
23.1 21.5 29.9 24.0 25.4 25.3 23.5 20.7 23.4 18.4
Dyspnea 6.9 12.2 8.1 8.1 7.3 9.1 9.1 7.1 6.1 10.1 0.455 0.012 0.784 0.001 0.616 0.080
18.5 24.5 16.3 20.8 15.8 21.6 17.2 20.0 13.1 15.6
Insomnia 13.0 23.0 31.8 22.2 26.2 19.1 27.3 31.3 28.3 25.3 0.301 0.016 0.681 0.002 0.741 0.005
24.4 29.9 31.2 32.7 35.0 29.0 29.4 35.3 30.2 23.6
Appetite loss 4.2 6.4 10.3 7.2 3.2 6.3 17.2 29.3 16.2 12.1 0.005 0.064 0.002 0.130 0.346 0.015
14.0 13.3 26.6 18.8 9.9 17.4 27.8 35.1 27.8 20.1 T1 > T3** Men <Women
Constipation 2.5 28.6 28.4 23.0 23.0 4.3 35.4 26.3 33.3 28.3 0.467 0.011 0.296 0.015 0.485 0.011
11.8 32.6 30.9 29.9 32.5 14.9 36.3 27.3 25.0 22.3
Diarrhea 2.5 23.0 23.4 22.2 23.0 3.1 23.2 24.2 20.2 14.1 0.402 0.013 0.504 0.006 0.448 0.012
10.4 25.0 26.3 21.7 22.7 12.6 22.8 25.4 26.3 18.7
Financial
difficulties
5.5 17.5 28.8 19.8 22.2 6.3 13.1 24.2 15.2 16.2 0.007 0.057 0.336 0.013 0.989 <0.001
17.8 29.7 26.4 25.6 30.1 18.6 24.9 33.6 23.7 26.5 T0 < T1*
T1 > T2**
Higher scores on functional scales and overall QOL scale indicate higher levels of function. Higher scores on symptoms scales or single items (#) indicate higher levels of symptoms or problems.













Table 3 EORTC QLQ-CR38 scores by time and gender
Questionnaire time points Main effect of time Main effect
of gender
Time-by-gender
interactionMen (n = 42) Women (n = 33)





(T0, T1, T2, T3)
(T1) (T2) (T3) (T1) (T2) (T3)
Mean Mean Mean Mean Mean Mean Mean Mean P values P values P values
SD SD SD SD SD SD SD SD
Functional scales/items
Body image
85.2 71.6 80.4 78.8 82.2 75.8 76.4 81.8 0.006 0.064 0.992 0.001 0.298 0.017
15.3 27.9 17.7 17.5 21.9 26.7 23.4 20.4 T0 > T1*
T1 < T2** T1 < T3**
Future perspective
60.3 55.4 61.1 62.7 55.6 45.5 57.6 62.6 0.025 0.045 0.281 0.016 0.634 0.007
25.8 34.8 26.5 26.8 28.5 33.2 19.2 21.7 T1 < T3*
Sexual functioning
21.8 18.7 21.0 14.7 14.3 4.2 7.1 7.7 0.009 0.059 0.002 0.133 0.146 0.024
21.6 19.6 17.7 14.8 19.1 9.8 15.3 16.7 T0 > T3* Men > Women
Sexual enjoyment 47.6 28.6 33.3 23.8 33.3 22.2 44.4 33.3 0.272 0.147 0.434 0.106 1.000 0.001
26.2 29.9 27.2 25.2 22.5 19.3 19.3 22.5
Symptom scales/items (#)
Micturition problems
19.1 37.2 24.6 22.8 10.1 26.3 19.2 15.8 < 0.001 0.171 0.014 0.080 0.668 0.006
21.7 27.5 17.1 17.2 12.5 21.1 17.6 15.5 T0 < T1*** T0 < T2* Men > Women
T1 > T2* T1 > T3**
Gastrointestinal tract symptoms
16.7 24.7 15.7 17.1 24.4 28.3 21.6 17.0 0.012 0.055 0.163 0.027 0.495 0.010
19.3 20.1 12.9 15.7 27.6 30.0 14.8 2.5 T1 > T2* T1 > T3*
Defecation problems
19.7 36.1 26.8 24.3 19.7 30.9 21.7 17.4 < 0.001 0.205 0.055 0.051 0.383 0.014
15.3 18.1 11.4 15.6 14.0 14.5 11.2 11.0 T0 < T1***
T1 > T2*** T1 > T3***
Weight loss
9.5 24.6 5.5 5.6 11.1 23.2 14.1 14.1 < 0.001 0.116 0.168 0.026 0.289 0.017
18.5 28.6 12.6 12.6 16.0 28.2 26.4 23.6 T0 < T1**
T1 > T2*** T1 > T3***
Higher scores on functional scales and overall QOL scale represent higher levels of functioning. Higher score on symptoms scales or single items (#) indicate higher levels of symptoms or problems.
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nificantly reduced after surgery. Moreover, the erectile
dysfunction rate increased after surgery, from 23.8% be-
fore to 54.8% 1 month after surgery, 42.9% 6 months
after surgery, and 40.5% 12 months after surgery. Fa-
tigue, financial difficulties, body image, micturition prob-
lems, defecation problems, and weight loss were worse
1 month after surgery. Baseline values for most of these
items were restored by 1 year after the operation. Other
factors did not change significantly during the 12 months
after surgery.
Correlations between global health status/QOL and
EORTC QLQ-C30/CR38 factors
Before surgery, there was a significant positive correlation
between global health status/QOL and all EORTC QLQ-
C30 functional scales (see Table 4). One month after sur-
gery, significant positive correlations were found between
global health status/QOL and all EORTC QLQ-C30 func-
tional scales, except cognitive functioning in women. In
addition, when we divided the sample according to gender
at 6 and 12 months after surgery, all of the significant rela-
tionships were found in the male group only. There were
no significant correlations between global health status/
QOL and EORTC QLQ-C30 functional scales among
women, with the exceptions of physical functioning at 6
and 12 months after surgery and social functioning at
12 months after surgery.
During the first year after SSS, a significant negative cor-
relation was found between global health status/QOL and
fatigue in both genders (see Table 5). Significant negative
correlations were found between global health status/QOL
and pain except 6 and 12 months after surgery in women.
Significant negative correlations were found between glo-
bal health status/QOL and financial difficulties except
6 months after surgery in women. Significant positive cor-
relations were found between global health status/QOL
and body image, except 6 months after surgery in women.
Significant positive correlations were found between global
health status/QOL and future perspective, except before
and 6 months after surgery in women. Significant positive
correlations were found between global health status/QOL
and sexual functioning and sexual enjoyment within 1 and
6 months after surgery. Significant negative correlations
were found between global health status/QOL and mictur-
ition problems within 6 and 12 months after surgery. Sig-
nificant negative correlations were found between global
health status/QOL and defecation problems except before
surgery, 6 and 12 months after surgery in women.
Regression predicting global health status/QOL in men
and women
Separate multiple linear regression analyses (stepwise)
were conducted for men and women to investigatepredictors of global health status/QOL (Figure 1) and
social functioning (Figure 2) 12 months after surgery.
Before surgery, the global health status/QOL of men was
significantly predicted by body image (β = 0.52) and fu-
ture perspective (β = 0.43) (F(2, 39) = 52.62, P < 0.001,
Adj. R2 = 0.62). Before surgery, the global health status/
QOL of women was significantly predicted by emotional
functioning (β = 0.47) and fatigue (β = −0.48) (F(2, 30) =
34.85, P < 0.001, Adj. R2 = 0.69), emotional functioning
was significantly predicted by fatigue (β = −0.54), and fu-
ture perspective (β = 0.35) (F(2, 30) = 12.39, P < 0.001,
Adj. R2 = 0.42) before surgery.
One month after surgery, the global health status/
QOL of men was significantly predicted by role func-
tioning (β = 0.33), fatigue (β = −0.27), future perspec-
tive (β = 0.24), and weight loss (β = −0.22) (F(4, 37) =
26.55, P < 0.001, Adj. R2 = 0.72). Role functioning was
significantly predicted by pain (β = −0.53), defecation
problems (β = −0.39), and financial difficulties (β = −0.20)
(F(3, 38) = 29.45, P < 0.001, Adj. R2 = 0.68). One month
after surgery, the global health status/QOL of women
was significantly predicted by fatigue (β = −0.52), future
perspective (β = 0.30), weight loss (β = −0.29), and de-
fecation problems (β = −0.26) (F(4, 28) = 23.34, P < 0.001,
Adj. R2 = 0.74).
Six months after surgery, the global health status/QOL
of men was significantly predicted by cognitive function-
ing (β = 0.35), fatigue (β = −0.42), and sexual enjoyment
(β = 0.38) (F(3, 38) = 17.68, P < 0.001, Adj. R2 = 0.55). Cog-
nitive functioning was significantly predicted by body
image (β = 0.49) (F(1, 40) = 14.15, P < 0.001, Adj. R2 =
0.39). Six months after surgery, the global health status/
QOL of women was significantly predicted by emotional
functioning (β = 0.27), fatigue (β = −0.48), sexual function-
ing (β = 0.37), and weight loss (β = −0.23) (F(4, 28) = 21.21,
P < 0.001, Adj. R2 = 0.72). Emotional functioning was sig-
nificantly predicted by financial difficulties (β = −0.50)
(F(1, 31) = 10.11, P < 0.001, Adj. R2 = 0.23).
Twelve months after surgery, the global health status/
QOL of men was significantly predicted by role function-
ing (β = 0.64) (F(1, 40) = 27.53, P < 0.001, Adj. R2 = 0.39).
Role functioning was significantly predicted by fatigue
(β = −0.43), pain (β = −0.38), and financial difficulties
(β = −0.23) (F(3, 38) = 44.50, P < 0.001, Adj. R2 = 0.76).
Twelve months after surgery, the global health status/QOL
of women was significantly predicted by fatigue (β = −0.42),
micturition problems (β = −0.39), and insomnia (β = −0.34)
(F(3, 29) = 22.58, P < 0.001, Adj. R2 = 0.68).
Twelve months after surgery, we found that men’s
scores on social functioning were inferior to women’s
scores. In men, social functioning was significantly pre-
dicted by pain (β = −0.52) and body image (β = 0.35) (F(2,
39) = 27.53, P < 0.001, Adj. R2 = 0.46). Twelve months after
surgery, social functioning in women was significantly
Table 4 Correlations between global health status/QOL scores and functional and symptom scales of EORTC QLQ-C30
EORTC C30


















Men R 0.306 0.484 0.733 0.334 0.726 −0.604 −0.070 −0.479 −0.351 −0.561 −0.258 −0.270 −0.168 −0.528
Before
Surgery
p 0.049 0.001 <0.001 0.031 <0.001 <0.001 0.658 0.001 0.023 <0.001 0.099 0.084 0.287 <0.001
Women R 0.543 0.680 0.779 0.516 0.646 −0.710 −0.017 −0.418 −0.283 −0.303 −0.365 −0.093 −0.393 −0.482




Men R 0.603 0.709 0.741 0.555 0.659 −0.642 −0.238 −0.656 −0.309 −0.524 −0.465 −0.082 −0.324 −0.336
p <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.129 <0.001 0.046 <0.001 0.002 0.608 0.036 0.029
Women R 0.561 0.579 0.680 0.342 0.658 −0.784 −0.175 −0.354 −0.018 −0.669 −0.590 −0.099 −0.183 −0.436




Men R 0.650 0.672 0.479 0.548 0.525 −0.692 −0.082 −0.589 −0.252 −0.456 −0.249 −0.414 −0.109 −0.365
p <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.608 <0.001 0.107 0.002 0.112 0.006 0.490 0.017
Women R 0.374 0.308 0.304 0.106 0.313 −0.611 −0.132 −0.168 −0.179 −0.290 −0.294 −0.176 −0.031 −0.314




Men R 0.650 0.672 0.479 0.548 0.525 −0.692 −0.082 −0.589 −0.252 −0.456 −0.249 −0.414 −0.109 −0.365
p <0.001 <0.001 0.001 <0.001 <0.001 <0.001 0.608 <0.001 0.107 0.002 0.112 0.006 0.490 0.017
Women R 0.469 0.328 0.338 0.335 0.532 −0.601 −0.405 −0.128 −0.053 −0.404 −0.470 −0.137 −0.091 −0.567













Table 5 Correlations between global health status/QOL scores and functional and symptom scales of EORTC QLQ-CR38
EORTC QLQ-CR38

















Before Surgery Men R 0.674 0.699 0.222 0.200 −0.137 −0.422 −0.349 −0.288
p <0.001 <0.001 0.158 0.397 0.387 0.005 0.025 0.064
Women R 0.585 0.167 0.144 0.546 −0.182 −0.377 −0.206 −0.355
p 0.001 0.354 0.455 0.129 0.312 0.031 0.266 0.043
1 month after surgery Men R 0.565 0.685 0.240 0.575 −0.241 −0.528 −0.527 −0.568
p <0.001 <0.001 0.125 0.025 0.124 <0.001 <0.001 0.001
Women R 0.602 0.543 0.063 0.278 −0.166 −0.437 −0.430 −0.330
p <0.001 0.001 0.733 0.594 0.357 0.011 0.012 0.061
6 months after surgery Men R 0.450 0.501 0.193 0.281 −0.311 −0.393 −0.538 −0.159
p 0.003 0.002 0.221 0.072 0.045 0.010 <0.001 0.315
Women R 0.205 0.247 0.549 0.415 −0.136 −0.083 −0.082 −0.100
p 0.252 0.165 0.001 0.016 0.452 0.644 0.650 0.582
12 months after surgery Men R 0.450 0.501 0.193 0.281 −0.311 −0.393 −0.538 −0.159
p 0.003 0.002 0.221 0.072 0.045 0.010 <0.001 0.315
Women R 0.352 0.469 0.211 0.218 −0.470 −0.213 −0.235 −0.154
p 0.044 0.006 0.247 0.230 0.006 0.234 0.188 0.391
Males (n = 42), females (n = 33). Higher scores on functional scales and overall QOL scale indicate higher levels of functioning. Higher scores on symptoms scale or
single items (#) indicate higher levels of symptoms or problems.
Kinoshita et al. World Journal of Surgical Oncology  (2015) 13:91 Page 10 of 14predicted by financial difficulties (β = −0.60), body image
(β = 0.29), and defecation problems (β = −0.23) (F(3, 29) =
22.58, P < 0.001, Adj. R2 = 0.76).
Discussion
This study attempted to show the longitudinal changes
in the QOL of patients with lower rectal cancer
12 months after SSS and to reveal gender differences in
QOL-related factors. Little is known about how patients’
QOL changes over time after SSS for lower rectal cancer
or whether gender is associated with different percep-
tions of QOL.
Hjermstad et al. found that Norwegian women re-
ported lower functional status and global health status/
QOL than men did, which corresponded with findings
in the general German population [16,17]. In our study,
scores for both genders were similar before surgery, but
most of the QOL scores changed after surgery, with
men having lower scores than women. However, this
may have been biased by longer overall duration treat-
ment in men. Before surgery, global health status/QOL
and social functioning scores exceeded the scores indi-
cating ‘poor’ QOL of the reference (German) population
by ten points. Global health status/QOL decreased
1 month after surgery and improved 6 months after
surgery.
Physical, role, and social functioning deteriorated signifi-
cantly 1 month after surgery, improved after 6 months,and returned to baseline levels within 12 months, with the
exception of role and social functioning in men. Role
functioning scores decreased conspicuously 1 month after
surgery, more than 20 points below the pre-surgery scores
for both genders. Women recovered 6 months after sur-
gery, but men did not recover by 12 months after surgery.
There were no significant changes in emotional or cogni-
tive functioning during the 12 months following surgery
for both groups. Andersson et al. reported that physical,
role, and social functioning deteriorated 1 month after
surgery, improved after 6 months, and returned to base-
line levels within 12 months [14]. For both genders, role
functioning scores on the EORTC QLQ-C30 decreased by
more than 30 points 1 month after surgery from the base-
line scores before surgery. This result was similar to our
findings.
In our study, role, cognitive, and social functioning in
men were more than ten points lower than the reference
(German) population of men 12 months after SSS. Fur-
thermore, men’s scores on the social functioning scale
12 months after surgery were significantly lower than
women’s scores, and the difference was over ten points.
Vironen et al. demonstrated that patients with rectal
cancer after surgery had poorer social functioning than
did a population control group [24]. Rauch et al. indicated
that stoma patients unexpectedly reported improved social
functioning in comparison to non-stoma patients, but a
gender effect was not reported [25].
Figure 1 Regression predicting global health status/QOL in men and women. Higher scores on the functional scales and overall QOL
scale indicate higher levels of function. Higher scores on the symptoms scales or single items (#) indicate higher levels of symptoms or
problems. *P < 0.05; **P < 0.01; ***P < 0.001.
Kinoshita et al. World Journal of Surgical Oncology  (2015) 13:91 Page 11 of 14Schmidt et al. reported that gender differences after
rectal cancer surgery included APR and SSS but not ISR
surgery [13]. Women had significantly lower global
health status/QOL and physical functioning scores, and
they scored worse in terms of fatigue. Men reportedreduced sexual enjoyment, and sexual problems were
greater among men over time, as indicated by lower
scores than those in the early postoperative period.
Our findings confirm that the QOL in patients with
lower rectal cancer changes with time post-surgery. We
Figure 2 Regression predicting social functioning at 12 months after surgery in men and women. Higher scores on the functional scales
and overall QOL scale indicate higher levels of function. Higher scores on the symptoms scales or single items (#) indicate higher levels of
symptoms or problems. *P < 0.05; **P < 0.01; ***P < 0.001.
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QOL, physical functioning, and fatigue across the gen-
der. Twelve months after surgery, men’s scores on the
social functioning scale were significantly lower than
women’s scores. Appetite loss was significantly better,
and micturition problems were significantly worse in
men post-surgery. Sexual functioning is reduced, and the
erectile dysfunction rate is increased post-surgery. Fa-
tigue, pain, appetite loss, future perspective, body image,
micturition problems, defecation problems, and weight
loss significantly improved within 12 months after sur-
gery. Changes in the other factors were not significant
within 12 months after surgery.
da Silva et al. reported that female patients showed
significant deterioration in their overall sexual function-
ing at 6 months after surgery, with a partial recovery by
12 months, and improvement in body image by
12 months [26]. In our study, the finding on body image
was similar, but sexual function did not change signifi-
cantly within 12 months post-surgery.
This study investigated the predictive ability of gen-
der with regard to QOL among patients with lower
rectal cancer who had undergone SSS within the last
12 months. Before surgery, our sample’s global health
status/QOL was more than ten points lower than the
reference data (German sample). To improve their glo-
bal health status/QOL before surgery, men could pay
more attention to their body image and sense of future
perspective, while women could focus on their emo-
tional functioning, fatigue, and future perspective. In
our study, global health status/QOL decreased slightly
in men 1 month after surgery. During this time, men
might need help addressing problems related to role
functioning, future perspective, and weight loss. Role
functioning was significantly predicted by pain, defecation
problems, and financial difficulties and showed the largest
decrease (more than 20 points below baseline) 1 month
after surgery. One month after surgery, women need helpwith fatigue, weight loss, defecation problems, and future
perspective.
In our study, global health status/QOL improved
6 months after surgery; however, men scored worse than
the reference population at 6 and 12 months after surgery.
Men need help with cognitive functioning, fatigue, and
sexual enjoyment to improve their global health status/
QOL 6 months following surgery. Cognitive functio-
ning was significantly predicted by body image. Within
12 months after surgery, men need help with role func-
tioning, which was significantly predicted by fatigue, pain,
and financial difficulties in our study.
Women appear to be affected by fatigue at all times
and weight loss, defecation problems, sexual functioning,
and micturition problems after surgery. Men appear to
be affected by body image and future perspective before
and 1 month after surgery. They were affected by
fatigue, weight loss, pain, and sexual enjoyment 6 and
12 months after surgery. Hendren et al. reported that
sexual dysfunction after surgery is common in both gen-
ders [27]. However, it does not seem to have a negative
impact on their global health status/QOL. However, in
our study, sexual dysfunction was related to global
health status/QOL and seemed to be different in the
follow-up months, which was likely due to the difference
in follow-up times between Hendren’s (29 to 160 months
after surgery) and our study [27].
Men’s scores on social functioning were lower than
were those of women at 12 months after surgery, and
social functioning was significantly predicted by pain
and body image. Pain was significantly correlated with
fatigue, insomnia, body image, future perspective,
defecation problems, and financial difficulties. Rauch
et al. suggested the consideration of the effects of
residual pain and constipation on long-term QOL when
creating and implementing a treatment plan [25]. Thus,
pain control and establishing bowel functioning are
important to QOL. In addition, in our study, most
Kinoshita et al. World Journal of Surgical Oncology  (2015) 13:91 Page 13 of 14patients had severe diarrhea and incontinence, and so
they were using antidiarrheal agent. Thus, we could not
properly evaluate this effect. Significant differences were
not found in global health status/QOL between genders,
and only social functioning in men at 12 months after
surgery was lower than that of the women. However, this
may have been biased by longer overall treatment dur-
ation in men. These factors may have prolonged the re-
covery of their social functioning. On the other hand,
patients with SSS are prone to developing a condition
called ‘low anterior resection syndrome,’ which includes
disturbances in bowel habits, ranging from increased
bowel frequency to fecal incontinence or evacuatory dys-
function. Konanz et al. describe that incontinence and
painful defecation are common problems [28].
Patients with SSS in our study were especially prone
to develop this syndrome. In our study, defecation, sexu-
ality, and micturition problems were correlated; however,
the correlations with fatigue were stronger than those
with QOL. Fatigue contributed to the prediction of QOL
in both groups during the 1-year period. Management
strategies for fatigue include psycho-educational interven-
tions, exercise programs, and pharmacological treatments
[29]. Engel et al. reported an improvement of EORTC
QLQ-C30 and CR38 scores of rectal cancer patients
treated with SSS in a 4-year prospective study on QOL
[30]. Thus, we think that a long-term prospective study is
necessary to improve the QOL of patients suffering from
the adverse effects of lower rectal cancer surgeries.
Conclusions
The present results suggest that gender is an important
consideration in explaining the QOL between individuals.
The identification of patients (in this case, gender) who
are likely to experience negative changes in their QOL will
help health care providers tailor treatment plans for indi-
vidual patients for best results. Nursing interventions that
are time sensitive and individualized should improve the
QOL of patients suffering from the adverse effects of SSS
for lower rectal cancer.
Relevance to clinical practice
Our results indicate that it is necessary to improve pa-
tients’ global health status/QOL, conduct an assessment
within 12 month after surgery, and help them to enhance
their social functioning.
Differences in QOL scores and related functions/
symptoms between genders suggest the need for a dif-
ferent approach towards improving their QOL by con-
trolling contributory factors. Treatment of fatigue is
essential towards this end. A considerable amount of
information about permanent stoma is available, but
less information about fatigue, defecation problems,
sexual problems, and micturition problems associatedwith SSS is accessible to the general public. Therefore,
more information about the patients’ experiences with
SSS is needed. The necessary components of a support
system should include the following: 1) information
on coping with fatigue, defecation, sexual problems,
micturition problems, and financial difficulties; and
(2) psychological support to improve patients’ body
image and future perspective. Services must be delivered
in a timely fashion, in multiple stages, and planned while
patients are awaiting SSS.
The information presented here provides valuable
knowledge on the predictors and factors associated with
QOL. With this knowledge, patients at risk for reduced
QOL can be identified and treated accordingly. Future
studies can use these findings, which can then become a
database for relevant guidelines.
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